ESR1 and breast cancer: As an invasive breast carcinoma, TNBC is characterized by the absence of expression of the estrogen receptor (ER), progesterone receptor (PgR), and human epidermal growth factor receptor-2 (HER2) proteins that belong to basal cell-like breast cancer.